Featured Research

from universities, journals, and other organizations

Children Found To Be Most At Risk From Malaria

Date:
October 2, 2009
Source:
BioMed Central
Summary:
Insecticide treated mosquito nets reduce the chances of developing life-threatening malaria in Africa, however recent research shows that older children are the least well protected by nets in the community. The research has found that parents and their young children were much more likely to have malaria nets than older children.

Insecticide treated mosquito nets reduce the chances of developing life-threatening malaria in Africa, however recent research shows that older children are the least well protected by nets in the community. The research, published in the open access journal BMC Public Health, has found that parents and their young children were much more likely to have malaria nets than older children.

"5-19 years olds are a particularly important group for two reasons," said lead researcher Abdisalan M Noor, from the Kenyan Medical Research Institute-Wellcome Trust Research Programme and the University of Oxford, "Firstly, they represent a large fraction of the population in most developing African communities. Secondly, while they may have developed a functional immune response against clinical disease before their fifth birthday, they will not have developed an immunity to the Malaria parasite and continue to contribute transmission in the community."

Noor and his colleagues report that, as an unintended consequence of attempting to achieve the targets of the Abuja declaration and Millennium Development Goals, children and adolescents over five are being put at risk. They said: "An estimated 80% of human-mosquito transmission comes from over-fives, with young adolescents and older children the peak age group. As a result, ensuring this age demographic is sufficiently protected from malaria should be viewed as important."

Noor concludes: "Where school attendance is high, the delivery of nets through schools should be considered an approach to reach universal coverage and improve the likelihood of impacting upon parasite transmission."


Story Source:

The above story is based on materials provided by BioMed Central. Note: Materials may be edited for content and length.


Journal Reference:

  1. Abdisalan M Noor, Viola C Kirui, Simon J Brooker and Robert W Snow. The use of insecticide treated nets by age: implications for universal coverage in Africa. BMC Public Health, 2009; (in press) [link]

Cite This Page:

BioMed Central. "Children Found To Be Most At Risk From Malaria." ScienceDaily. ScienceDaily, 2 October 2009. <www.sciencedaily.com/releases/2009/09/090930194258.htm>.
BioMed Central. (2009, October 2). Children Found To Be Most At Risk From Malaria. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/09/090930194258.htm
BioMed Central. "Children Found To Be Most At Risk From Malaria." ScienceDaily. www.sciencedaily.com/releases/2009/09/090930194258.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins